Komo

Specialty ingredients and nutrient systems

What is Balchem?

Balchem is a specialty ingredients and nutrient systems company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.

Category
Specialty ingredients and nutrient systems
Headquarters
Montvale, NJ
Founded
See official company history
Employees
See latest annual report and company filings
Total funding
Public company
Status
Public company; Nasdaq: BCPC

What is Balchem?

Balchem is a specialty ingredients and nutrient systems company headquartered in Montvale, NJ. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.

Balchem is a specialty ingredients and nutrient systems company headquartered in Montvale, NJ. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.

For sellers, Balchem should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.

What does Balchem offer?

Balchem's profile centers on Human nutrition, Animal nutrition, Specialty products, Encapsulation.

  • Human nutrition· Specialty ingredients and nutrient systems
  • Animal nutrition· Specialty ingredients and nutrient systems
  • Specialty products· Specialty ingredients and nutrient systems
  • Encapsulation· Specialty ingredients and nutrient systems
  • Minerals and nutrients· Specialty ingredients and nutrient systems
  • Food ingredients· Specialty ingredients and nutrient systems

How does Balchem make money?

Balchem makes money through commercial activity tied to specialty ingredients and nutrient systems.

Balchem monetizes through the model common to specialty ingredients and nutrient systems: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.

Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.

Who leads Balchem?

Balchem's named executives should be verified on the official leadership or investor-relations page before outreach.

  • Balchem executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
  • Balchem finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
  • Balchem operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.

How do you contact Balchem's leadership?

Balchem should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.

Email formatcontact via https://www.balchem.com

How is Balchem funded?

Balchem's current status is Public company; Nasdaq: BCPC.

Balchem's capital profile is best understood through its current public-company status: Public company; Nasdaq: BCPC. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.

Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.

How did Balchem get here?

Balchem's history should be read through founding, scale-up, public-market ownership, and current product or market focus.

  1. FoundingBalchem is foundedThe company begins building in specialty ingredients and nutrient systems.
  2. Scale-upCommercial footprint expandsBalchem broadens its product, customer, distribution, or geographic reach.
  3. Public marketsPublic company; Nasdaq: BCPCPublic-company ownership shapes reporting, procurement, and operating priorities.
  4. 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
  5. June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.

Who are Balchem's competitors?

Balchem competes with larger incumbents and focused specialists in specialty ingredients and nutrient systems.

  • Thermo Fisher ScientificLife sciences tools and services incumbent.
  • DanaherLife sciences and diagnostics platform company.
  • MedtronicGlobal medical technology competitor.
  • PfizerLarge pharmaceutical company.
  • IQVIAHealthcare data and clinical research platform.

Balchem — frequently asked questions

Agent CTA Background

Revenue work. On autopilot.

Start Free TrialBuilt for revenue teams who care about quality.